BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 28811289)

  • 1. Primary Tumors Limit Metastasis Formation through Induction of IL15-Mediated Cross-Talk between Patrolling Monocytes and NK Cells.
    Kubo H; Mensurado S; Gonçalves-Sousa N; Serre K; Silva-Santos B
    Cancer Immunol Res; 2017 Sep; 5(9):812-820. PubMed ID: 28811289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre-metastatic cancer exosomes induce immune surveillance by patrolling monocytes at the metastatic niche.
    Plebanek MP; Angeloni NL; Vinokour E; Li J; Henkin A; Martinez-Marin D; Filleur S; Bhowmick R; Henkin J; Miller SD; Ifergan I; Lee Y; Osman I; Thaxton CS; Volpert OV
    Nat Commun; 2017 Nov; 8(1):1319. PubMed ID: 29105655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ly49 family receptors are required for cancer immunosurveillance mediated by natural killer cells.
    Tu MM; Mahmoud AB; Wight A; Mottashed A; Bélanger S; Rahim MM; Abou-Samra E; Makrigiannis AP
    Cancer Res; 2014 Jul; 74(14):3684-94. PubMed ID: 24802191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endogenous galectin-3 expression levels modulate immune responses in galectin-3 transgenic mice.
    Chaudhari AD; Gude RP; Kalraiya RD; Chiplunkar SV
    Mol Immunol; 2015 Dec; 68(2 Pt A):300-11. PubMed ID: 26442663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IFN-γ production by lung NK cells is critical for the natural resistance to pulmonary metastasis of B16 melanoma in mice.
    Takeda K; Nakayama M; Sakaki M; Hayakawa Y; Imawari M; Ogasawara K; Okumura K; Smyth MJ
    J Leukoc Biol; 2011 Oct; 90(4):777-85. PubMed ID: 21712396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patrolling Monocytes Control NK Cell Expression of Activating and Stimulatory Receptors to Curtail Lung Metastases.
    Narasimhan PB; Eggert T; Zhu YP; Marcovecchio P; Meyer MA; Wu R; Hedrick CC
    J Immunol; 2020 Jan; 204(1):192-198. PubMed ID: 31767784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antitumoral efficacy by systemic delivery of cationic liposome-plasmid interleukin-15 complexes in murine models of lung metastasis].
    Teng X; Zhou XK; Zhang YB; Qiu J; Mao YQ; Deng HX; Li J
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Feb; 28(2):148-52. PubMed ID: 22304773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. INAM plays a critical role in IFN-γ production by NK cells interacting with polyinosinic-polycytidylic acid-stimulated accessory cells.
    Kasamatsu J; Azuma M; Oshiumi H; Morioka Y; Okabe M; Ebihara T; Matsumoto M; Seya T
    J Immunol; 2014 Nov; 193(10):5199-207. PubMed ID: 25320282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IRF-1 expression is essential for natural killer cells to suppress metastasis.
    Ksienzyk A; Neumann B; Nandakumar R; Finsterbusch K; Grashoff M; Zawatzky R; Bernhardt G; Hauser H; Kröger A
    Cancer Res; 2011 Oct; 71(20):6410-8. PubMed ID: 21900395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Innate and adoptive immune cells contribute to natural resistance to systemic metastasis of B16 melanoma.
    Umeshappa CS; Zhu Y; Bhanumathy KK; Omabe M; Chibbar R; Xiang J
    Cancer Biother Radiopharm; 2015 Mar; 30(2):72-8. PubMed ID: 25714591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defective antitumor responses in CX3CR1-deficient mice.
    Yu YR; Fong AM; Combadiere C; Gao JL; Murphy PM; Patel DD
    Int J Cancer; 2007 Jul; 121(2):316-22. PubMed ID: 17372897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of NOX2-Derived Reactive Oxygen Species in NK Cell-Mediated Control of Murine Melanoma Metastasis.
    Aydin E; Johansson J; Nazir FH; Hellstrand K; Martner A
    Cancer Immunol Res; 2017 Sep; 5(9):804-811. PubMed ID: 28760732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. hIL-15 gene-modified human natural killer cells (NKL-IL15) augments the anti-human hepatocellular carcinoma effect in vivo.
    Jiang W; Zhang C; Tian Z; Zhang J
    Immunobiology; 2014 Jul; 219(7):547-53. PubMed ID: 24721706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-12 activates NK cells for IFN-gamma-dependent and NKT cells for IFN-gamma-independent antimetastatic activity.
    Hafner M; Falk W; Echtenacher B; Männel DN
    Eur Cytokine Netw; 1999 Dec; 10(4):541-8. PubMed ID: 10586121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the Superagonist Complex, ALT-803, to IL15 as Cancer Immunotherapeutics in Animal Models.
    Rhode PR; Egan JO; Xu W; Hong H; Webb GM; Chen X; Liu B; Zhu X; Wen J; You L; Kong L; Edwards AC; Han K; Shi S; Alter S; Sacha JB; Jeng EK; Cai W; Wong HC
    Cancer Immunol Res; 2016 Jan; 4(1):49-60. PubMed ID: 26511282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patrolling monocytes control tumor metastasis to the lung.
    Hanna RN; Cekic C; Sag D; Tacke R; Thomas GD; Nowyhed H; Herrley E; Rasquinha N; McArdle S; Wu R; Peluso E; Metzger D; Ichinose H; Shaked I; Chodaczek G; Biswas SK; Hedrick CC
    Science; 2015 Nov; 350(6263):985-90. PubMed ID: 26494174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer immunosurveillance: role of patrolling monocytes.
    Cassetta L; Pollard JW
    Cell Res; 2016 Jan; 26(1):3-4. PubMed ID: 26634605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An improved method to study NK-independent mechanisms of MTLn3 breast cancer lung metastasis.
    van Nimwegen MJ; Verkoeijen S; Kuppen PJ; Velthuis JH; van de Water B
    Clin Exp Metastasis; 2007; 24(5):379-87. PubMed ID: 17541710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High dose CD11c-driven IL15 is sufficient to drive NK cell maturation and anti-tumor activity in a trans-presentation independent manner.
    Polansky JK; Bahri R; Divivier M; Duitman EH; Vock C; Goyeneche-Patino DA; Orinska Z; Bulfone-Paus S
    Sci Rep; 2016 Jan; 6():19699. PubMed ID: 26822794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of natural killer and T-cells in interferon induced inhibition of spontaneous metastases of the B16F10L murine melanoma.
    Markovic SN; Murasko DM
    Cancer Res; 1991 Feb; 51(4):1124-8. PubMed ID: 1705166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.